SFL Managing Director Provides Further Update Regarding Revision of EU Medtech Legislation
Summary
“In my presentations, I will address how they can become more adept at interpreting upcoming rules concerning their products, and implement appropriate action for their daily business operations.” Ms. Fürst-Ladani is the Managing Director and founder of SFL.In 2012, she received the Open University Business School’s Alumni Award Outstanding “Contribution to an Organization.” A number of her articles regarding medical device regulation and related regulatory areas are available on the SFL website.Ms. Fürst-Ladani’s recognised expertise in this complex field, which includes serving as chair of the SwAPP (Swiss Association of Pharmaceutical Professionals) Medical Device Task Force, will see her giving presentations at two upcoming Swiss life science events.On 25 November, Ms. Fürst-Ladani will be presenting at the i-net/BioValley Stammtisch event in Basel and on 27 November, she will speak at the SwAPP Annual Meeting in Bern.In her presentations, as well as examining the major technological and regulatory trends that are shaping the EU’s medtech regulatory landscape, she will focus on the practical implications for stakeholders in Switzerland.“A wide array of companies will be affected by the ongoing legislative changes, including manufacturers of medical devices, in vitro diagnostics, drug/device combination products and borderline products,” commented Ms. Fürst-Ladani.Contact Information SFL Regulatory Affairs & Scientific Communication Ltd Faiz Kermani +41 61 361 9443 www.sfl-services.com Hochstrasse 51, CH-4002 Basel, Switzerland Click here to view the list of recent Press Releases from SFL Regulatory Affairs & Scientific Communication Ltd Promote Your Business Press Release Pricing Email this page to a friend